Silva-Tirado MP

Language: Spanish
References: 14
Page: 325-331
PDF size: 208.00 Kb.

ABSTRACT

DRESS syndrome is a severe and idiosyncratic reaction of hypersensitivity to drugs, characterized by rash, fever, lymphadenopathy, hematological alterations and systemic compromise, the heterogeneity of the clinical presentation represents a diagnostic challenge for the clinician, a high clinical suspicion is required and the need to rule out a wide spectrum of differential diagnoses. Cutaneous reactions associated with drugs can be potentially fatal, early diagnosis can modify the patient’s prognosis. We describe the clinical case and treatment of a 15-year-old male patient with chronic renal failure who was hospitalized for generalized morbilliform lesions associated with fever, lymphadenopathy, splenomegaly and eosinophilia. Complementary studies ruled out infectious, autoimmune and neoplastic processes; the antecedent of recent intake of allopurinol together with clinical and laboratory data allowed to establish a definitive diagnosis of DRESS syndrome. Patient received topical and systemic corticosteroids, clinical manifestations reverted from the second week of hospitalization. We emphasize the importance of identifying risk factors associated with the development of this syndrome.

REFERENCES

1. Lee J, Lee S, Hahm J, Ha J, Kim C, Kim S. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. Int J Dermatol 2017;56(9):944-951.

2. Agu CC, Basheer H. DRESS syndrome associated with allopurinol. Int J Case Rep Images 2014;5(2):145-149.

3. Silva M, Ortiz E, Rojas M, Muñoz D. DRESS síndrome in paediatrics. Clinical case. Rev Chil Pediatr 2017;88(1):158-163.

4. Waseem D, Muzamil L, Najeebullah S, Imtiyaz D, Gayoom K, Farhat A, et al. Dress syndrome: A review and update. Skin Diseases & Skin Care 2016:1(1:8).

5. Hassan S, Wetz R, Zouein E. Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis. Int J Gen Med 2011;4:789-792.

6. Cho Y, Yang Ch, Chu Ch. Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system. Int J Mol Sci 2017;18:1243; doi:10.3390/ijms18061243

7. Cacoub P, Musette P, Descamps V, Meyer O, Speirs Ch, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med 2011;124(7):588-596.

8. Stamp L, Day R, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol Advance online publication 29 September 2015; doi:10.1038/nrrheum.2015.132

9. Ramasamy S, Korb-Wells C, Kannangara D, Smtih M, Wang N, Roberts D, et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf 2013;36:953-980.

10. Ruiz J, Méndez S, Domínguez J. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. An Bras Dermatol 2017;92(1):30-3.

11. Saksita N, Tassaneeyakula W, Nakkama N, Konyoungi P, Khunarkornsirii U, Chumworathayib P, Sukasemj Ch, et al. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Pharmacogenet Genomics 2017.

12. Hande K, Noone R, Stone W. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984;76:47-56.

13. Shalon R, Rimbroth S. Case report. Allopurinol-induced recurrent DRESS syndrome: Pathophysiology and treatment. Renal Failure 2008;30:327-329.

14. Kardau SH, Sekula P, Valeyrie- Allanore L, Liss Y, Chu CY, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dematol 2013;169:1071-1080.